Results 321 to 330 of about 9,618,511 (343)

Cannabis Resin Extract in Parkinson’s Disease: Behavioral, Neurochemical, and Histological Evaluation

Cell Biology: Research & Therapy, 2014
Cannabis sativa (Family Cannabaceae, L.) has been used in China and India for thousands of years as a medicine. The main active constituents of cannabis are Δ 9 -tetrahydrocannabinol (THC), cannabinol (CBN) and cannabidiol (CBD). Currently, THC and CBD are being carefully used in conditions, such as multiple sclerosis, cancer pain, and chemotherapy ...
openaire   +1 more source

PARKINSON’S DISEASE CLASSIFICATION USING HYBRID NAMIB SQUIRREL SEARCH WATER ALGORITHM-BASED DEEP LEARNING APPROACH

International Journal for Multiscale Computational Engineering
Parkinson's disease (PD) is a neurological disease throughout the globe, and it is the second leading reason for death and impairment. The overall cases of PD have nearly doubled in the past 15 years. It has been defined by the absence of dopamine cells in the brain.
S. Sharanyaa, Jimsha K. Mathew, Kavitha R. Nair, Muthulakshmi Arumugasamy   +3 more
openaire   +1 more source

Parkinson’s disease and hospital admissions: frequencies, diagnoses and costs

Acta Neurologica Scandinavica, 2010
C. Vossius, O. B. Nilsen, J. P. Larsen
openaire   +1 more source

Staging of brain pathology related to sporadic Parkinson’s disease

Neurobiology of Aging, 2003
H. Braak, K. Tredici, U. Rüb, R. Vos, Ernst N. H. Jansen Steur, E. Braak   +5 more
semanticscholar   +1 more source

Ageing and Parkinson's disease: substantia nigra regional selectivity.

Brain : a journal of neurology, 1991
J. Fearnley, A. J. Lees
semanticscholar   +1 more source

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

, 1997
M. Polymeropoulos, C. Lavedan, E. Leroy, S. E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W. Johnson, A. Lazzarini, R. Duvoisin, G. Iorio, L. Golbe, R. Nussbaum   +19 more
semanticscholar   +1 more source

Clinical diagnostic criteria for dementia associated with Parkinson's disease

Movement Disorders, 2007
M. Emre, D. Aarsland, Richard G. Brown, D. Burn, C. Duyckaerts, Y. Mizuno, G. Broe, J. Cummings, D. Dickson, S. Gauthier, J. Goldman, C. Goetz, A. Korczyn, A. Lees, R. Levy, I. Litvan, I. McKeith, W. Olanow, W. Poewe, N. Quinn, C. Sampaio, E. Tolosa, B. Dubois   +22 more
semanticscholar   +1 more source

Stages in the development of Parkinson’s disease-related pathology

Cell and Tissue Research, 2004
H. Braak, E. Ghebremedhin, U. Rüb, H. Bratzke, K. Tredici   +4 more
semanticscholar   +1 more source

α-Synuclein Locus Triplication Causes Parkinson's Disease

Science, 2003
A. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, Michael Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, K. Gwinn‐Hardy   +21 more
semanticscholar   +1 more source

The prevalence of Parkinson's disease: A systematic review and meta‐analysis

Movement Disorders, 2014
T. Pringsheim, N. Jetté, A. Frolkis, T. Steeves   +3 more
semanticscholar   +1 more source